InvestmentMay 5, 2026, 05:12 PM
PURE Bioscience Raises $1.0M in Private Placement
AI Summary
PURE Bioscience, Inc. completed a private placement financing on April 30, 2026, raising $1.0 million from accredited investors. The company issued 18,131,096 shares of common stock at a price of $0.0553 per share. Board members Tom Y. Lee and Ivan Chen participated, investing approximately $700,000 and $27,650, respectively. The net proceeds are earmarked for general corporate purposes, including research and development efforts, administrative expenses, and working capital.
Key Highlights
- PURE Bioscience raised $1.0 million in a private placement financing.
- The company issued 18,131,096 shares of common stock.
- Shares were sold at a purchase price of $0.0553 per share.
- Board member Tom Y. Lee invested approximately $700,000.
- Board member Ivan Chen invested $27,650.
- Net proceeds will be used for general corporate purposes, including R&D and working capital.
Price Impact
More from PURE